Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed)

The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting applications for a Coccidioidomycosis Collaborative Research Centers (CCRC) program to support the development of a Valley fever vaccine. The program aims to establish highly collaborative, multi-disciplinary research teams to conduct translational and clinical research. Key areas of focus include addressing gaps in basic Coccidioides research, developing tools and resources, and developing a preventative vaccine. • The CCRCs will leverage unique research resources and patient populations from endemic regions to advance the field. • Applications are due by July 09, 2026, and the earliest start date for the award is March 2027. • The award will be for 5 years, and the estimated funding is $4,800,000, with an award ceiling of $1,200,000. • Applicants must submit a Data Management and Sharing Plan and comply with applicable laws and regulations, including those related to cybersecurity.